Skip to Content

GG 623 GG 623 (Terazosin Hydrochloride 5 mg)

Pill with imprint GG 623 GG 623 is Pink, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 623 GG 623

Terazosin hydrochloride 5 mg GG 623 GG 623
Terazosin hydrochloride 5 mg GG 623 GG 623
Terazosin hydrochloride 5 mg GG 623 GG 623

Terazosin Hydrochloride

Imprint:
GG 623 GG 623
Strength:
5 mg
Color:
Pink
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
corn starch
crospovidone
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
lactose monohydrate
magnesium stearate
microcrystalline cellulose
shellac
propylene glycol
ferrosoferric oxide
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00904-6128 Major Pharmaceuticals
54569-4875 A-S Medication Solutions, LLC (repackager)
54868-4248 Physicians Total Care Inc. (repackager)
67544-0084 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide